Journal article
Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination
Abstract
BACKGROUND: Millions of women have been vaccinated with one of two first-generation human papillomavirus (HPV) vaccines. Both vaccines remain in use and target two oncogenic types (HPVs 16 and 18); however, if these types naturally compete with others that are not targeted, type replacement may occur following reductions in the circulating prevalence of targeted types. To explore the potential for type replacement, we evaluated natural HPV type …
Authors
Tota JE; Jiang M; Ramanakumar AV; Walter SD; Kaufman JS; Coutlée F; Richardson H; Burchell AN; Koushik A; Mayrand MH
Journal
PLOS ONE, Vol. 11, No. 12,
Publisher
Public Library of Science (PLoS)
DOI
10.1371/journal.pone.0166329
ISSN
1932-6203